TT, what really doesn’t make much sense is why would the company use CR money in its recent raise to fund manufacturing capacity at its plant if the ultimate plan is to sell the company off to a bidder?
Wouldn’t you agree that is somewhat inconsistent? Maybe the idea is to increase manufacturing capacity to align with increased sales and increased trial use. Ramping up production capacity is more a medium to long term strategy rather than a shorter term flip objective.
- Forums
- ASX - By Stock
- Ann: Two more PANCOSIL Trial treatments using OncoSil device
OSL
oncosil medical ltd
Add to My Watchlist
20.6%
!
$1.23

TT, what really doesn’t make much sense is why would the company...
Featured News
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
|
|||||
Last
$1.23 |
Change
0.210(20.6%) |
Mkt cap ! $17.49M |
Open | High | Low | Value | Volume |
$1.05 | $1.24 | $1.03 | $200.2K | 169.6K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 3500 | $1.19 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$1.25 | 60000 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 3500 | 1.190 |
1 | 90 | 1.160 |
1 | 325 | 1.130 |
1 | 5000 | 1.120 |
1 | 7500 | 1.080 |
Price($) | Vol. | No. |
---|---|---|
1.250 | 60000 | 1 |
0.000 | 0 | 0 |
0.000 | 0 | 0 |
0.000 | 0 | 0 |
0.000 | 0 | 0 |
Last trade - 16.10pm 26/06/2025 (20 minute delay) ? |
Featured News
OSL (ASX) Chart |
The Watchlist
PTX
PRESCIENT THERAPEUTICS LIMITED
James McDonnell, CEO
James McDonnell
CEO
Previous Video
Next Video
SPONSORED BY The Market Online